See more : Ditto (Thailand) Public Company Limited (DITTO.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Realcan Pharmaceutical Group Co., Ltd. (002589.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Realcan Pharmaceutical Group Co., Ltd., a leading company in the Medical – Distribution industry within the Healthcare sector.
- Dollar Tree, Inc. (DT3.DE) Income Statement Analysis – Financial Results
- Mondelez International, Inc. (KTF.DE) Income Statement Analysis – Financial Results
- Yamabiko Corporation (6250.T) Income Statement Analysis – Financial Results
- Tokai Tokyo Financial Holdings, Inc. (8616.T) Income Statement Analysis – Financial Results
- Godrej Consumer Products Limited (GODREJCP.NS) Income Statement Analysis – Financial Results
Realcan Pharmaceutical Group Co., Ltd. (002589.SZ)
About Realcan Pharmaceutical Group Co., Ltd.
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. It sells drugs, vaccines, and medical devices. The company also provides medical logistics services; third-party logistics services; disinfection and sterilization; and lease, and hospital logistics services for medical institutions. It serves drug distribution, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medical care, professional logistics, and comprehensive equipment. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.03B | 12.31B | 21.06B | 27.20B | 35.26B | 33.92B | 23.29B | 15.62B | 9.75B | 7.79B | 5.93B | 4.62B | 3.20B | 2.21B | 1.60B | 1.15B |
| Cost of Revenue | 7.21B | 10.64B | 17.22B | 22.23B | 28.44B | 27.42B | 19.00B | 13.17B | 8.68B | 7.08B | 5.42B | 4.25B | 2.93B | 2.03B | 1.46B | 1.05B |
| Gross Profit | 822.06M | 1.67B | 3.84B | 4.98B | 6.82B | 6.49B | 4.30B | 2.45B | 1.07B | 705.38M | 509.16M | 376.91M | 261.76M | 183.75M | 137.64M | 101.64M |
| Gross Profit Ratio | 10.23% | 13.58% | 18.23% | 18.29% | 19.34% | 19.15% | 18.44% | 15.67% | 10.97% | 9.06% | 8.59% | 8.15% | 8.19% | 8.30% | 8.59% | 8.86% |
| Research & Development | 39.54M | 22.68M | 11.56M | 8.91M | 6.97M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 170.64M | 304.69M | 428.13M | 534.32M | 663.14M | 705.00M | 469.75M | 209.41M | 107.13M | 41.28M | 26.60M | 24.54M | 22.33M | 17.07M | 15.19M | 11.60M |
| Selling & Marketing | 260.66M | 847.15M | 1.74B | 2.17B | 2.65B | 2.16B | 1.51B | 931.97M | 408.62M | 234.03M | 136.89M | 95.92M | 63.43M | 39.74M | 29.00M | 22.38M |
| SG&A | 846.00M | 1.15B | 2.17B | 2.71B | 3.31B | 2.87B | 1.97B | 1.14B | 515.75M | 275.31M | 163.49M | 120.47M | 85.76M | 56.81M | 44.19M | 33.97M |
| Other Expenses | 63.15M | 430.45M | 621.51M | 662.24M | 904.93M | 780.74M | 415.30M | 16.87M | 9.55M | 6.02M | -1.26M | 32.99M | -1.03M | 16.80M | 12.03M | 12.03M |
| Operating Expenses | 948.70M | 1.60B | 2.80B | 3.38B | 4.22B | 3.65B | 2.39B | 1.41B | 648.99M | 378.90M | 236.23M | 167.20M | 116.02M | 76.72M | 58.81M | 46.85M |
| Cost & Expenses | 8.16B | 12.24B | 20.02B | 25.61B | 32.66B | 31.07B | 21.39B | 14.59B | 9.33B | 7.46B | 5.65B | 4.41B | 3.05B | 2.11B | 1.52B | 1.09B |
| Interest Income | 190.71M | 83.97M | 136.34M | 103.01M | 86.55M | 52.60M | 28.46M | 20.79M | 14.63M | 3.64M | 4.40M | 4.53M | 4.39M | 1.53M | 476.62K | 279.34K |
| Interest Expense | 323.35M | 407.71M | 554.42M | 590.12M | 737.11M | 576.25M | 196.46M | 105.20M | 88.25M | 77.65M | 68.67M | 38.55M | 23.77M | 14.19M | 10.06M | 7.22M |
| Depreciation & Amortization | 219.68M | 316.76M | 363.64M | 337.80M | 329.43M | 267.07M | 158.88M | 84.27M | 43.12M | 24.49M | 11.80M | 7.90M | 6.21M | 4.59M | 3.68M | 2.84M |
| EBITDA | 439.43M | -960.82M | 1.34B | 1.80B | 1.38B | 2.98B | 2.02B | 1.06B | 449.83M | 343.90M | 273.97M | 194.39M | 142.42M | 101.96M | 73.89M | 48.54M |
| EBITDA Ratio | 5.47% | -4.41% | 7.69% | 7.33% | 7.98% | 8.66% | 8.67% | 7.37% | 5.01% | 4.61% | 4.82% | 4.66% | 4.70% | 4.76% | 4.72% | 4.41% |
| Operating Income | -126.64M | 67.11M | 1.30B | 1.70B | 2.54B | 2.70B | 1.81B | 861.34M | 308.94M | 235.77M | 195.31M | 151.94M | 113.55M | 85.14M | 62.89M | 39.64M |
| Operating Income Ratio | -1.58% | 0.55% | 6.17% | 6.26% | 7.20% | 7.96% | 7.77% | 5.51% | 3.17% | 3.03% | 3.30% | 3.29% | 3.55% | 3.85% | 3.93% | 3.46% |
| Total Other Income/Expenses | -8.78M | -27.29M | -835.22M | -787.77M | -2.44B | -749.21M | 102.24K | -95.06M | 9.52M | 5.99M | -1.80M | -41.04M | -25.72M | -20.64M | -12.38M | -8.12M |
| Income Before Tax | -135.42M | -1.74B | 465.02M | 915.48M | 102.38M | 1.96B | 1.81B | 878.07M | 318.46M | 241.76M | 193.50M | 147.84M | 112.44M | 83.18M | 60.09M | 38.47M |
| Income Before Tax Ratio | -1.69% | -14.17% | 2.21% | 3.37% | 0.29% | 5.79% | 7.77% | 5.62% | 3.27% | 3.11% | 3.27% | 3.20% | 3.52% | 3.76% | 3.75% | 3.35% |
| Income Tax Expense | -167.39M | -4.44M | 83.01M | 290.93M | 537.36M | 684.83M | 441.92M | 203.00M | 75.32M | 60.00M | 49.26M | 37.17M | 28.41M | 21.04M | 15.28M | 9.29M |
| Net Income | 20.32M | -1.74B | 382.01M | 624.55M | -434.98M | 1.28B | 1.37B | 590.76M | 235.94M | 180.99M | 143.55M | 110.65M | 84.06M | 62.11M | 44.76M | 29.18M |
| Net Income Ratio | 0.25% | -14.13% | 1.81% | 2.30% | -1.23% | 3.77% | 5.87% | 3.78% | 2.42% | 2.32% | 2.42% | 2.39% | 2.63% | 2.81% | 2.79% | 2.54% |
| EPS | 0.01 | -1.18 | 0.26 | 0.42 | -0.29 | 0.86 | 0.91 | 0.44 | 0.19 | 0.18 | 0.16 | 0.13 | 0.11 | 0.10 | 0.08 | 0.06 |
| EPS Diluted | 0.01 | -1.18 | 0.26 | 0.42 | -0.29 | 0.86 | 0.91 | 0.44 | 0.19 | 0.18 | 0.16 | 0.13 | 0.11 | 0.10 | 0.08 | 0.06 |
| Weighted Avg Shares Out | 1.51B | 1.47B | 1.47B | 1.47B | 1.50B | 1.48B | 1.50B | 1.35B | 1.23B | 991.12M | 880.47M | 862.44M | 750.80M | 642.03M | 579.95M | 488.07M |
| Weighted Avg Shares Out (Dil) | 1.51B | 1.47B | 1.47B | 1.47B | 1.50B | 1.48B | 1.50B | 1.35B | 1.23B | 991.12M | 880.47M | 862.71M | 750.80M | 642.03M | 579.95M | 488.07M |
Source: https://incomestatements.info
Category: Stock Reports